• EEPD1 deficiency exacerbates radiation-induced cardiac hypertrophy and apoptosis, while overexpression is protective.
• EEPD1 directly interacts with FOXO3A and promotes its deubiquitination, leading to FOXO3A degradation.
• FOXO3A inhibition reverses the detrimental effects of EEPD1 knockdown, confirming the EEPD1-FOXO3A axis as a key pathway.
• This study identifies EEPD1 as a potential therapeutic target for mitigating radiation-induced heart disease.